Kristen B Farrell

ORCID

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 10

Top Venues

The Journal of pharmacology and experimental therapeutics

PloS one

This page only lists publications with an associated author ORCID identifier.

Publications

Kristen B Farrell, Sunetra Das, Steven K Nordeen, James R Lambert, Douglas H Thamm
VDX-111 targets proliferative pathways in canine cancer cell lines. PloS one 19 (5) (2024)
Lisa J Schlein, Samuel A Brill, Rachel V Brady, Kristen B Farrell, Barbara J Rose, Travis K Meuten, Craig T Jordan, Douglas H Thamm
Parthenolide As a Therapeutic for Disseminated Canine Neoplasms. The Journal of pharmacology and experimental therapeutics 388 (3) (2024)
Lisa J Schlein, Samuel A Brill, Rachel V Brady, Kristen B Farrell, Barbara J Rose, Travis K Meuten, Craig T Jordan, Douglas H Thamm
Parthenolide As a Therapeutic for Disseminated Canine Neoplasms. The Journal of pharmacology and experimental therapeutics 388 (3) (2024)
Lisa J Schlein, Samuel A Brill, Rachel V Brady, Kristen B Farrell, Barbara J Rose, Travis K Meuten, Craig T Jordan, Douglas H Thamm
Parthenolide As a Therapeutic for Disseminated Canine Neoplasms. The Journal of pharmacology and experimental therapeutics 388 (3) (2024)
Lisa J Schlein, Samuel A Brill, Rachel V Brady, Kristen B Farrell, Barbara J Rose, Travis K Meuten, Craig T Jordan, Douglas H Thamm
Parthenolide As a Therapeutic for Disseminated Canine Neoplasms. The Journal of pharmacology and experimental therapeutics 388 (3) (2024)
Lisa J Schlein, Samuel A Brill, Rachel V Brady, Kristen B Farrell, Barbara J Rose, Travis K Meuten, Craig T Jordan, Douglas H Thamm
Parthenolide As a Therapeutic for Disseminated Canine Neoplasms. The Journal of pharmacology and experimental therapeutics 388 (3) (2024)
Lisa J Schlein, Samuel A Brill, Rachel V Brady, Kristen B Farrell, Barbara J Rose, Travis K Meuten, Craig T Jordan, Douglas H Thamm
Parthenolide As a Therapeutic for Disseminated Canine Neoplasms. The Journal of pharmacology and experimental therapeutics 388 (3) (2024)
Lisa J Schlein, Samuel A Brill, Rachel V Brady, Kristen B Farrell, Barbara J Rose, Travis K Meuten, Craig T Jordan, Douglas H Thamm
Parthenolide As a Therapeutic for Disseminated Canine Neoplasms. The Journal of pharmacology and experimental therapeutics 388 (3) (2024)
Kristen B Farrell, Sunetra Das, Steven K Nordeen, James R Lambert, Douglas H Thamm
VDX-111 targets proliferative pathways in canine cancer cell lines. PloS one 19 (5) (2024)
Lisa J Schlein, Samuel Brill, Rachel Brady, Kristen B Farrell, Barbara J Rose, Travis Meuten, Craig T Jordan, Douglas H Thamm
Parthenolide as a therapeutic for disseminated canine neoplasms . The Journal of pharmacology and experimental therapeutics (2023)

Kristen B Farrell.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Kristen B Farrell